Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Invested Capital (2021 - 2022)

Ovid Therapeutics' Return on Invested Capital history spans 2 years, with the latest figure at 0.41% for Q4 2022.

  • For Q4 2022, Return on Invested Capital fell 106.0% year-over-year to 0.41%; the TTM value through Dec 2022 reached 0.41%, down 106.0%, while the annual FY2021 figure was 1.09%, N/A changed from the prior year.
  • Return on Invested Capital reached 0.41% in Q4 2022 per OVID's latest filing, up from 0.47% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.65% in Q4 2021 to a low of 0.47% in Q3 2022.